Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101920
Status:
COMPLETED
Last Update Posted:
2010-10-15
First Post:
2005-01-18
Brief Title:
ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer NSCLC
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20025408
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Global Development Leader
Old Organization:
Amgen Inc